245 related articles for article (PubMed ID: 32034306)
1. EGFR activates GDH1 transcription to promote glutamine metabolism through MEK/ERK/ELK1 pathway in glioblastoma.
Yang R; Li X; Wu Y; Zhang G; Liu X; Li Y; Bao Y; Yang W; Cui H
Oncogene; 2020 Apr; 39(14):2975-2986. PubMed ID: 32034306
[TBL] [Abstract][Full Text] [Related]
2. α-Ketoglutarate-Activated NF-κB Signaling Promotes Compensatory Glucose Uptake and Brain Tumor Development.
Wang X; Liu R; Qu X; Yu H; Chu H; Zhang Y; Zhu W; Wu X; Gao H; Tao B; Li W; Liang J; Li G; Yang W
Mol Cell; 2019 Oct; 76(1):148-162.e7. PubMed ID: 31447391
[TBL] [Abstract][Full Text] [Related]
3. Correction: EGFR activates GDH1 transcription to promote glutamine metabolism through MEK/ERK/ELK1 pathway in glioblastoma.
Yang R; Li X; Wu Y; Zhang G; Liu X; Li Y; Bao Y; Yang W; Cui H
Oncogene; 2022 Sep; 41(36):4257-4258. PubMed ID: 35831581
[No Abstract] [Full Text] [Related]
4. LncRNA XLOC_006390 promotes pancreatic carcinogenesis and glutamate metabolism by stabilizing c-Myc.
He J; Li F; Zhou Y; Hou X; Liu S; Li X; Zhang Y; Jing X; Yang L
Cancer Lett; 2020 Jan; 469():419-428. PubMed ID: 31734356
[TBL] [Abstract][Full Text] [Related]
5. CXXC finger protein 4 inhibits the CDK18-ERK1/2 axis to suppress the immune escape of gastric cancer cells with involvement of ELK1/MIR100HG pathway.
Li P; Ge D; Li P; Hu F; Chu J; Chen X; Song W; Wang A; Tian G; Gu X
J Cell Mol Med; 2020 Sep; 24(17):10151-10165. PubMed ID: 32715641
[TBL] [Abstract][Full Text] [Related]
6. ERK/ribosomal S6 kinase (RSK) signaling positively regulates death receptor 5 expression through co-activation of CHOP and Elk1.
Oh YT; Liu X; Yue P; Kang S; Chen J; Taunton J; Khuri FR; Sun SY
J Biol Chem; 2010 Dec; 285(53):41310-9. PubMed ID: 21044953
[TBL] [Abstract][Full Text] [Related]
7. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
Mut M; Lule S; Demir O; Kurnaz IA; Vural I
Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
[TBL] [Abstract][Full Text] [Related]
8. Glutamate dehydrogenase 1: A novel metabolic target in inhibiting acute myeloid leukaemia progression.
Ma Z; Ye W; Wang J; Huang X; Huang J; Li X; Hu C; Li C; Zhou Y; Lin X; Wei W; Qian Y; Zhou Y; Mao S; Yin X; Zhu B; Jin J
Br J Haematol; 2023 Aug; 202(3):566-577. PubMed ID: 37231991
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
10. EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma.
Fang R; Chen X; Zhang S; Shi H; Ye Y; Shi H; Zou Z; Li P; Guo Q; Ma L; He C; Huang S
Nat Commun; 2021 Jan; 12(1):177. PubMed ID: 33420027
[TBL] [Abstract][Full Text] [Related]
11. Kr-POK (ZBTB7c) regulates cancer cell proliferation through glutamine metabolism.
Hur MW; Yoon JH; Kim MY; Ko H; Jeon BN
Biochim Biophys Acta Gene Regul Mech; 2017 Aug; 1860(8):829-838. PubMed ID: 28571744
[TBL] [Abstract][Full Text] [Related]
12. Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition.
Clark PA; Iida M; Treisman DM; Kalluri H; Ezhilan S; Zorniak M; Wheeler DL; Kuo JS
Neoplasia; 2012 May; 14(5):420-8. PubMed ID: 22745588
[TBL] [Abstract][Full Text] [Related]
13. EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival.
Roos A; Dhruv HD; Peng S; Inge LJ; Tuncali S; Pineda M; Millard N; Mayo Z; Eschbacher JM; Loftus JC; Winkles JA; Tran NL
Mol Cancer Res; 2018 Jul; 16(7):1185-1195. PubMed ID: 29724813
[TBL] [Abstract][Full Text] [Related]
14. EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.
Yang W; Xia Y; Cao Y; Zheng Y; Bu W; Zhang L; You MJ; Koh MY; Cote G; Aldape K; Li Y; Verma IM; Chiao PJ; Lu Z
Mol Cell; 2012 Dec; 48(5):771-84. PubMed ID: 23123196
[TBL] [Abstract][Full Text] [Related]
15. LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling.
Xiao Q; Dong M; Cheng F; Mao F; Zong W; Wu K; Wang H; Xie R; Wang B; Lei T; Guo D
Int J Oncol; 2018 Sep; 53(3):1069-1082. PubMed ID: 30015847
[TBL] [Abstract][Full Text] [Related]
16. MYST1/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cells.
Dong Z; Zou J; Li J; Pang Y; Liu Y; Deng C; Chen F; Cui H
Cancer Med; 2019 Dec; 8(18):7793-7808. PubMed ID: 31691527
[TBL] [Abstract][Full Text] [Related]
17. Elevated microRNA-130b-5p or silenced ELK1 inhibits self-renewal ability, proliferation, migration, and invasion abilities, and promotes apoptosis of cervical cancer stem cells.
Huang Y; Luo F
IUBMB Life; 2021 Jan; 73(1):118-129. PubMed ID: 33295145
[TBL] [Abstract][Full Text] [Related]
18. Tumor-suppressive miRNA-135a inhibits breast cancer cell proliferation by targeting ELK1 and ELK3 oncogenes.
Ahmad A; Zhang W; Wu M; Tan S; Zhu T
Genes Genomics; 2018 Mar; 40(3):243-251. PubMed ID: 29892795
[TBL] [Abstract][Full Text] [Related]
19. Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling.
Lerner-Marmarosh N; Miralem T; Gibbs PE; Maines MD
Proc Natl Acad Sci U S A; 2008 May; 105(19):6870-5. PubMed ID: 18463290
[TBL] [Abstract][Full Text] [Related]
20. Glutaminolysis Was Induced by TGF-β1 through PP2Ac Regulated Raf-MEK-ERK Signaling in Endothelial Cells.
Guo Y; Deng Y; Li X; Ning Y; Lin X; Guo S; Chen M; Han M
PLoS One; 2016; 11(9):e0162658. PubMed ID: 27612201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
